KMTS (KMTS) reported D&A of $1.98M in Q4 2025.

How has KMTS's D&A changed year-over-year?

KMTS's D&A increased by 5.0% year-over-year, from $1.89M to $1.98M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

KMTS KMTS D&A

D&A at other companies

Boston ScientificBSX

$351M+8.0%

MedtronicMDT

$716M-14.8%

iRhythm Holdings, Inc. IRTC

$5.04M-3.2%

Merit Medical SystemsMMSI

$30.5M+4.1%

HaemoneticsHAE

$27.32M-3.2%

ICU MedicalICUI

$50.03M+1.2%

Other financials

Income statement

See full

Revenue$24.6M+62.7%

Gross profit$12.9M+97.1%

Operating income-$34.8M-68.8%

Net income-$34.2M-58.8%

EPS (diluted)-$0.61+51.2%

Balance sheet

See full

Cash & equivalents$291.3M+436%

Total debt$43.8M—

Total assets$379.3M—

Cash flow

See full

Operating cash flow-$18.4M-2.1%

CapEx$9.8M+141%

Free cash flow-$28.2M-27.7%

Valuation

See full

Market cap$1.29B+70.8%

Enterprise value$1.04B—

P/S15.4×—

Profitability

See full

Gross margin48.8%+15.1pp

Operating margin-171.5%+12.9pp

Net margin-173%+0.8pp

FCF margin-142.9%-25.3pp

Returns & leverage

See full

Current ratio7.3×—

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KMTS's D&A?: KMTS (KMTS) reported D&A of $1.98M in Q4 2025.
How has KMTS's D&A changed year-over-year?: KMTS's D&A increased by 5.0% year-over-year, from $1.89M to $1.98M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.